StonvexLoading…
StonvexCore line items from CBLL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $27.83M | $26.49M | $89.06M | $64.28M | $41.69M |
Operating Income | Not available | $-20.75M | $-58.40M | $-43.81M | $-29.16M |
Net Income | Not available | $-19.74M | $-53.41M | $-39.88M | $-13.64M |
EPS (Diluted) | $-0.48 | $-0.52 | $-1.46 | $-1.10 | $-0.73 |
Total Assets | Not available | $178.08M | $195.80M | $199.53M | $207.69M |
Total Liabilities | Not available | $37.27M | $40.47M | $35.44M | $35.53M |
Cash & Equivalents | Not available | $45.25M | $40.48M | $23.74M | $40.14M |
Free Cash Flow OCF − CapEx | Not available | $-19.42M | $-41.58M | $-30.62M | $-19.16M |
Shares Outstanding | Not available | 37.86M | 37.49M | 37.05M | 36.60M |